Literature DB >> 8046701

Biopsy proven polymyositis in Victoria 1982-1987: analysis of prognostic factors.

H Lilley1, X Dennett, E Byrne.   

Abstract

Prognostic factors were analysed in 77 patients with idiopathic inflammatory myopathy identified over a 5 year period. Formal statistical tests did not differentiate useful prognostic indices and a polymyositis disability score was devised in an attempt to gain some prognostic information. Partial (47%) or full (31%) recovery were seen in most cases with no recovery of strength (9%) and death (11%) being less common outcomes. Onset before the age of 50 and duration of symptoms of less than 12 months prior to presentation were favourable prognostic features, and treatment with regimes other than steroid therapy alone a probable favourable indicator. Level of creatine kinase (CK) at presentation and histopathological separation of dermatomyositis or polymyositis failed to alter prognosis. Most patients who died did so within the initial 6 months of treatment. Four of five patients < 50 years old with either a fatal outcome or no improvement were treated with steroids alone. Large multi-centre studies are required to provide reliable data about prognostic factors in idiopathic inflammatory myopathies and the methodology used in this study can only be regarded as providing pointers towards possible prognostic factors rather than being definitive.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8046701      PMCID: PMC1294559          DOI: 10.1177/014107689408700608

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  14 in total

Review 1.  The functional role of the muscle spindles--facts and hypotheses.

Authors:  R Granit
Journal:  Brain       Date:  1975-12       Impact factor: 13.501

2.  Survival in polymyositis: corticosteroids and risk factors.

Authors:  J R Carpenter; T W Bunch; A G Engel; P C O'Brien
Journal:  J Rheumatol       Date:  1977       Impact factor: 4.666

3.  Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis.

Authors:  A Bohan; J B Peter; R L Bowman; C M Pearson
Journal:  Medicine (Baltimore)       Date:  1977-07       Impact factor: 1.889

Review 4.  Dermatomyositis and malignancy. A review of the literature.

Authors:  B E Barnes; B Mawr
Journal:  Ann Intern Med       Date:  1976-01       Impact factor: 25.391

5.  Recent advances in investigation of polymyositis.

Authors:  K G Henriksson
Journal:  Acta Neurol Scand Suppl       Date:  1980

6.  Muscle breakdown and repair in polymyositis: a case study.

Authors:  R H Edwards; C M Wiles; J M Round; M J Jackson; A Young
Journal:  Muscle Nerve       Date:  1979 May-Jun       Impact factor: 3.217

7.  Presentation, treatment, and prognosis of idiopathic inflammatory muscle disease in a rural hospital.

Authors:  G S Hoffman; W A Franck; D A Raddatz; L Stallones
Journal:  Am J Med       Date:  1983-09       Impact factor: 4.965

8.  The relationship of dermatomyositis and polymyositis to internal malignancy.

Authors:  J P Callen; J F Hyla; G G Bole; D R Kay
Journal:  Arch Dermatol       Date:  1980-03

9.  Polymyositis--treatment and prognosis. A study of 107 patients.

Authors:  K G Henriksson; P Sandstedt
Journal:  Acta Neurol Scand       Date:  1982-04       Impact factor: 3.209

10.  The ischemic exercise test in normal adults and in patients with weakness and cramps.

Authors:  R A Coleman; J M Stajich; V W Pact; M A Pericak-Vance
Journal:  Muscle Nerve       Date:  1986 Mar-Apr       Impact factor: 3.217

View more
  1 in total

1.  Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle.

Authors:  Iago Pinal-Fernandez; Cassie Parks; Jessie L Werner; Jemyma Albayda; Julie Paik; Sonye K Danoff; Livia Casciola-Rosen; Lisa Christopher-Stine; Andrew L Mammen
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-12-31       Impact factor: 4.794

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.